Anatomical Therapeutic Chemical (ATC) Classification

[ Brite menu | Download htext | Download json ]
    

1st Level  2nd Level  3rd Level  4th Level  5th Level  6th Level 

 A ALIMENTARY TRACT AND METABOLISM
   A01 STOMATOLOGICAL PREPARATIONS
   A02 DRUGS FOR ACID RELATED DISORDERS
   A03 DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS
   A04 ANTIEMETICS AND ANTINAUSEANTS
   A05 BILE AND LIVER THERAPY
   A06 DRUGS FOR CONSTIPATION
   A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS
   A08 ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS
   A09 DIGESTIVES, INCL. ENZYMES
   A10 DRUGS USED IN DIABETES
     A10A INSULINS AND ANALOGUES
     A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
       A10BA Biguanides [DG:DG01684]
       A10BB Sulfonylureas
       A10BC Sulfonamides (heterocyclic)
       A10BD Combinations of oral blood glucose lowering drugs
         A10BD01 Phenformin and sulfonylureas
         A10BD02 Metformin and sulfonylureas
         A10BD03 Metformin and rosiglitazone
         A10BD04 Glimepiride and rosiglitazone
         A10BD05 Metformin and pioglitazone
         A10BD06 Glimepiride and pioglitazone
           D09848  Pioglitazone hydrochloride and glimepiride tablets (JP17) <JP/US>
         A10BD07 Metformin and sitagliptin
         A10BD08 Metformin and vildagliptin
         A10BD09 Pioglitazone and alogliptin
         A10BD10 Metformin and saxagliptin
         A10BD11 Metformin and linagliptin
         A10BD12 Pioglitazone and sitagliptin
         A10BD13 Metformin and alogliptin
         A10BD14 Metformin and repaglinide
         A10BD15 Metformin and dapagliflozin
         A10BD16 Metformin and canagliflozin
         A10BD17 Metformin and acarbose
         A10BD18 Metformin and gemigliptin
         A10BD19 Linagliptin and empagliflozin
         A10BD20 Metformin and empagliflozin
         A10BD21 Saxagliptin and dapagliflozin
         A10BD22 Metformin and evogliptin
         A10BD23 Metformin and ertugliflozin
         A10BD24 Sitagliptin and ertugliflozin
         A10BD25 Metformin, saxagliptin and dapagliflozin
       A10BF Alpha glucosidase inhibitors [DG:DG01803]
       A10BG Thiazolidinediones [DG:DG01683]
       A10BH Dipeptidyl peptidase 4 (DPP-4) inhibitors [DG:DG01601]
       A10BJ Glucagon-like peptide-1 receptor (GLP-1) analogues
       A10BK Sodium-glucose co-transporter 2 (SGLT2) inhibitors
       A10BX Other blood glucose lowering drugs, excl. insulins
     A10X OTHER DRUGS USED IN DIABETES
   A11 VITAMINS
   A12 MINERAL SUPPLEMENTS
   A13 TONICS
   A14 ANABOLIC AGENTS FOR SYSTEMIC USE
   A15 APPETITE STIMULANTS
   A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
 
 B BLOOD AND BLOOD FORMING ORGANS
 
 C CARDIOVASCULAR SYSTEM
 
 D DERMATOLOGICALS
 
 G GENITO URINARY SYSTEM AND SEX HORMONES
 
 H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
 
 J ANTIINFECTIVES FOR SYSTEMIC USE
 
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
 
 M MUSCULO-SKELETAL SYSTEM
 
 N NERVOUS SYSTEM
 
 P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
 
 R RESPIRATORY SYSTEM
 
 S SENSORY ORGANS
 
 V VARIOUS

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: June 17, 2019
According to WHO's ATC 2019

» Japanese version